EUVIMEDEUVIMED entdecken
Crossref

IL-17A induces valvular endothelial inflammation and aggravates calcific aortic valve disease

Zhao Yang, Jichao Zhang, Yuexin Zhu, Congcong Zhang, Guang Li, Shuo Liu, Jie Du, Yingchun Han, Bin You

Biochemical and Biophysical Research Communications · 2023-09 · 672 · 145-153

DOI: 10.1016/j.bbrc.2023.04.079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023-09. Verfasst von Zhao Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Anzhen Hospital, Capital Medical University, Beijing, China; Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing, China. Hauptthemen laut MEDLINE: Aortic Valve, Aortic Valve Stenosis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Calcific aortic valve disease (CAVD) is an aging related disease characterized by inflammation and fibrocalcific remodeling. IL-17A is a key cytokine associated with pathophysiology of inflammatory and fibrotic disease. Previous studies showed accumulation of IL-17A-producing T helper lymphocytes in human calcified aortic valves and significantly elevated IL-17RA expression in calcified valves. However, the role of IL-17A signaling in the initiation and development of CAVD is still unclear. In this study, by analyzing public transcriptome databases, we found that IL-17A-IL-17RA signaling is activated in calcified valves. Gene expression analysis revealed significantly increased IL-17A, IL-17RA, and RUNX2 expression in calcified human aortic valves compared to in non-calcified valves, and the expression of IL-17A and IL-17RA were positively correlated with RUNX2 expression. A 5/6 nephrectomy was performed in Apoe-/- (Apoe knockout) mice to establish a CAVD mouse model. IL-17A-neutralizing antibodies significantly reduced valve calcium deposition and decreased expression of RUNX2 in aortic valves. Immunofluorescence staining of human aortic valves and qRT-PCR analysis of primary aortic valve cells revealed abundant expression of IL-17RA in valvular endothelial cells (VECs). RNA sequencing indicated that IL-17A promoted the activation of inflammatory signaling pathways in VECs. Furthermore, qRT-PCR and cytometric bead array analysis confirmed that IL-17A promoted the expression or secretion of inflammatory cytokines IL-6 and IL-1β, chemokines CXCL2 and CXCL8, and fibrosis-related gene COL16A1. Our findings indicate that elevated IL-17A in CAVD may promote valve inflammation, fibrosis, and calcification by inducing endothelial activation and inflammation. Targeting IL-17A-IL-17RA signaling may be a potential therapeutic strategy for CAVD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic ValveAortic Valve StenosisApolipoproteins EInterleukin-17InflammationEndothelial CellsCells, CulturedCore Binding Factor Alpha 1 SubunitHumansCytokinesMiceAnimalsFibrosisCalcinosis

Stichwörter der Autor:innen

Calcific aortic valve diseaseFibrosisIL-17AInflammationValve endothelial cells

Substanzen

Core Binding Factor Alpha 1 SubunitInterleukin-17CytokinesApolipoproteins E

Autor:innen und Institutionen

  • Beijing Anzhen Hospital, Capital Medical University, Beijing, China; Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing, China.
  • Beijing Anzhen Hospital, Capital Medical University, Beijing, China; Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing, China. Electronic address: hanyingchun.wfl@163.com.
  • Beijing Anzhen Hospital, Capital Medical University, Beijing, China; Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing, China. Electronic address: dr_youbin@vip.sina.com.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Yang, Z., Zhang, J., Zhu, Y., Zhang, C., Li, G., Liu, S., Du, J., Han, Y., & You, B. (2023). IL-17A induces valvular endothelial inflammation and aggravates calcific aortic valve disease. Biochemical and Biophysical Research Communications, 672, 145-153. https://doi.org/10.1016/j.bbrc.2023.04.079

Vancouver

Yang Z, Zhang J, Zhu Y, Zhang C, Li G, Liu S, et al. IL-17A induces valvular endothelial inflammation and aggravates calcific aortic valve disease. Biochemical and Biophysical Research Communications. 2023;672:145-153. doi:10.1016/j.bbrc.2023.04.079

BibTeX
@article{Yang2023,
  author = {Yang, Zhao and Zhang, Jichao and Zhu, Yuexin and Zhang, Congcong and Li, Guang and Liu, Shuo and Du, Jie and Han, Yingchun and You, Bin},
  title = {IL-17A induces valvular endothelial inflammation and aggravates calcific aortic valve disease},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2023},
  volume = {672},
  pages = {145--153},
  doi = {10.1016/j.bbrc.2023.04.079}
}
Kostenlos starten →